Replies to post #324706 on Avid Bioservices Inc (CDMO)

[biopharm]

The Supreme Court upheld in 2011 a previous ruling that if “disclosure of the omitted fact would have been viewed by the reasonable investor as having significantly altered the ‘total mix’ of information made available,” a public company’s failure to reveal certain information is considered “material” and could potentially subject it to civil and criminal investigation.

Bfiest, very interesting but one key is why they never told us about the meeting with Texas Board of Regents